BIIB115
- Generic Name
- BIIB115
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-12
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Biogen
- Target Recruit Count
- 62
- Registration Number
- NCT05575011
- Locations
- 🇳🇱
Centre For Human Drug Research, Leiden, Netherlands
🇳🇱UMC Utrecht, Utrecht, Netherlands
🇫🇷Hôpital Armand Trousseau, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath